Skip to content

Veracyte, Inc.

VCYT· NasdaqCore metricsCIK 1384101

Medical laboratories28 peers

Last sale
Nov 12, 2026 · -1.91%
Market cap
$1.99B
80.7M shares
Filings
1,034
$151.75M
Q3 2026+16.0% FY25 yoy
$31.50M
Q3 2026+174.9% FY25 yoy
$16.57M
Q3 2026+257.9% FY25 yoy
$113.14M
Q3 2026derived+98.5% FY25 yoy
$0.38
Q3 2026+164.5% FY25 yoy
$199.83M
Q3 2026+51.7% FY25 yoy
$1.99B
15.7×
3.4×
1.4×
8.15%
—

Twelve months to Sep 30, 2026 · derived

Price

$24.6142.31%$18.05past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$517.15MFY 2025
$517.15M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$517,145,000reported
FY 20242024-12-31$445,764,000reported
FY 20232023-12-31$361,051,000reported
FY 20222022-12-31$296,536,000reported
FY 20212021-12-31$219,514,000reported
FY 20202020-12-31$117,483,000reported
FY 20192019-12-31$120,368,000reported
FY 20182018-12-31$92,008,000reported
FY 20172017-12-31$71,953,000reported
FY 20162016-12-31$65,085,000reported
FY 20152015-12-31$49,503,000reported
FY 20142014-12-31$38,190,000reported

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $91.77MInternational · FY2018 · $235.00KFY2019United States · FY2019 · $119.15MInternational · FY2019 · $1.22MFY2020United States · FY2020 · $109.61MInternational · FY2020 · $7.87MFY2021United States · FY2021 · $200.98MInternational · FY2021 · $18.53MFY2022United States · FY2022 · $262.92MInternational · FY2022 · $33.61MFY2023United States · FY2023 · $334.53MInternational · FY2023 · $26.53MFY2024United States · FY2024 · $423.54MInternational · FY2024 · $22.23MFY2025United States · FY2025 · $496.60MInternational · FY2025 · $20.55M
LineFY2025ShareChange
United States$496.60M96%+17.3%
International$20.55M4.0%−7.6%
Total$517.15M

From the 10-K filed Feb 26, 2026VCYT

Medical laboratories

Veracyte, Inc. is the 8th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Veracyte, Inc. · CIK 1384101 · Engraved from SEC EDGAR